The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment
Abstract
:1. Introduction
2. Epidemiology
2.1. SARS-CoV
2.2. MERS-CoV
2.3. SARS-CoV-2
3. Clinical Manifestations of SARS-CoV-2
4. Transmission
4.1. Human-to-Human Transmission
4.2. Transmission Model
5. Infection Prevention and Control Methods
5.1. Recommendation by the WHO
5.2. Recommendations by Various Governments and Agencies
6. Therapy
6.1. Antiviral Therapy
6.2. Antibiotic Therapy
6.3. Fusion Proteins
6.4. mRNA Vaccines
6.5. DNA Vaccines
6.6. Cellular Therapy
6.7. Epitope Targeting for Vaccine Design
6.8. Cases of Successful Treatment
6.9. Recommendations Based on Present Knowledge Gathered in the First 75 Days of COVID-19 Outbreak
7. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Nicks, B.A. 2019 Novel Coronavirus (2019-nCoV): What We Currently Know; Medscape: New York, NY, USA, 2020; p. 2. [Google Scholar]
- Phan, T. Novel Coronavirus: From Discovery to Clinical Diagnostics; Esevier: Amsterdam, The Netherlands, 2020; p. 1. [Google Scholar]
- Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020, 395, 565–574. [Google Scholar] [CrossRef] [Green Version]
- Letko, M.; Marzi, A.; Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733. [Google Scholar] [CrossRef] [PubMed]
- Fung, T.S.; Liu, D.X. Human Coronavirus: Host-Pathogen Interaction. Annu. Rev. Microbiol. 2019, 73, 529–557. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gorbalenya, A.E.; Barker, S.C.; Baric, S.R.; de Groot, J.R.; Drosten, C.; Gulyaeva, A.A.; Haagmans, B.L.; Lauber, C.; Leontovich, A.M.; Neuman, B.W.; et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses—A statement of the Coronavirus Study Group. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Peiris, J.S.M.; Lai, S.T.; Poon, L.L.M.; Guan, Y.; Yam, L.Y.C.; Lim, W.; Nicholls, J.; Yee, W.K.S.; Yan, W.W.; Cheung, M.T.; et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361, 1319–1325. [Google Scholar] [CrossRef] [Green Version]
- Li, W. Bats Are Natural Reservoirs of SARS-Like Coronaviruses. Science 2005, 310, 676–679. [Google Scholar] [CrossRef]
- Wang, L.-F.; Shi, Z.; Zhang, S.; Field, H.; Daszak, P.; Eaton, B.T. Review of Bats and SARS. Emerg. Infect. Dis. 2006, 12, 1834–1840. [Google Scholar] [CrossRef]
- De Groot, R.J.; Baker, S.C.; Baric, R.S.; Brown, C.S.; Drosten, C.; Enjuanes, L.; Fouchier, R.A.M.; Galiano, M.; E Gorbalenya, A.; Memish, Z.A.; et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J. Virol. 2013, 87, 7790–7792. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2020. Available online: https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) (accessed on 5 February 2020).
- Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513. [Google Scholar] [CrossRef] [Green Version]
- Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L.; et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273. [Google Scholar] [CrossRef] [Green Version]
- Mahase, E. China coronavirus: What do we know so far? BMJ 2020, 368. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jiang, S.; Du, L.; Shi, Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: Calling for developing therapeutic and prophylactic strategies. Emerg. Microbes Infect. 2020, 9, 275–277. [Google Scholar] [CrossRef] [PubMed]
- Dong, N.; Yang, X.; Ye, L.; Chen, K.; Chan, E.; Yang, M.; Chen, S. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Zhao, Y.; Zhao, Z.; Wang, Y.; Zhou, Y.; Ma, Y.; Zuo, W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv 2020. [Google Scholar] [CrossRef]
- Rothe, C.; Schunk, M.; Sothmann, P.; Bretzel, G.; Froeschl, G.; Wallrauch, C.; Zimmer, T.; Thiel, V.; Janke, C.; Guggemos, W.; et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020, 382, 970–971. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chan, J.F.-W.; Yuan, S.; Kok, K.-H.; To, K.K.-W.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C.C.-Y.; Poon, R.W.-S.; et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020, 395, 514–523. [Google Scholar] [CrossRef] [Green Version]
- Phan, L.T.; Nguyen, T.V.; Luong, Q.C.; Nguyen, T.V.; Nguyen, H.T.; Le, H.Q.; Nguyen, T.T.; Cao, T.M.; Pham, Q.D. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N. Engl. J. Med. 2020, 382, 872–874. [Google Scholar] [CrossRef] [Green Version]
- Wu, J.T.; Leung, K.; Leung, G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet 2020, 395, 689–697. [Google Scholar] [CrossRef] [Green Version]
- Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.; Lau, E.H.; Wong, J.Y.; et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N. Engl. J. Med. 2020. [Google Scholar] [CrossRef]
- Jaillon, S.; Berthenet, K.; Garlanda, C. Sexual Dimorphism in Innate Immunity. Clin. Rev. Allergy Immunol. 2017, 56, 308–321. [Google Scholar] [CrossRef] [PubMed]
- National Health Commission of the People’s Republic of China. COVID-19 Outbreak Prevention, Control and Notification. Available online: http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml (accessed on 13 February 2020).
- World Health Organization. Coronavirus Disease (COVID-2019) Situation Reports. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed on 13 February 2020).
- Roser, M.; Ritchie, H.; Ortiz-Ospina, E. Coronavirus Disease (COVID-19)—Statistics and Research. Available online: https://ourworldindata.org/coronavirus (accessed on 13 February 2020).
- Zhao, S.; Musa, S.S.; Lin, Q.; Ran, J.; Yang, G.; Wang, W.; Lou, Y.; Yang, L.; Gao, D.; He, D.; et al. Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak. J. Clin. Med. 2020, 9, 388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization Regional Office for Europe. 2019-nCoV Outbreak is an Emergency of International Concern. Available online: http://www.euro.who.int/en/health-topics/health-emergencies/international-health-regulations/news/news/2020/2/2019-ncov-outbreak-is-an-emergency-of-international-concern (accessed on 6 February 2020).
- Guan, W.-J.; Ni, Z.-Y.; Hu, Y.; Liang, W.-H.; Ou, C.-Q.; He, J.; Liu, L.; Shan, H.; Lei, C.-L.; Hui, D.S.; et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
- Otter, J.; Donskey, C.; Yezli, S.; Douthwaite, S.; Goldenberg, S.; Weber, D. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination. J. Hosp. Infect. 2016, 92, 235–250. [Google Scholar] [CrossRef] [Green Version]
- Lei, J.; Li, J.; Li, X.; Qi, X. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology 2020, 295, 200236. [Google Scholar] [CrossRef] [Green Version]
- Chung, M.; Bernheim, A.; Mei, X.; Zhang, N.; Huang, M.; Zeng, X.; Cui, J.; Xu, W.; Yang, Y.; Fayad, A.Z.; et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020, 295, 200230. [Google Scholar] [CrossRef] [Green Version]
- Lei, H.; Li, Y.; Xiao, S.; Lin, C.-H.; Wei, D.; Hu, Z.; Ji, S.; Norris, S.L. Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: Comparative analyses. Indoor Air 2018, 28, 394–403. [Google Scholar] [CrossRef] [Green Version]
- Zumla, A.; Hui, D.S.; Perlman, S. Middle East respiratory syndrome. Lancet 2015, 386, 995–1007. [Google Scholar] [CrossRef] [Green Version]
- Chan, J.F.-W.; Kok, K.-H.; Zhu, Z.; Chu, H.; To, K.K.-W.; Yuan, S.; Yuen, K.-Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020, 9, 221–236. [Google Scholar] [CrossRef] [Green Version]
- Cohen, J. WHO Panel Puts off Decision on Whether to Sound Alarm on Rapid Spread of New Virus; AAAS: Washington, DC, USA, 2020. [Google Scholar]
- Kupferschmidt, K. Outbreak of Virus from China Declared Global Emergency; AAAS: Washington, DC, USA, 2020. [Google Scholar]
- Kupferschmidt, K. Study Claiming New Coronavirus can be Transmitted by People Without Symptoms was Flawed; AAAS: Washington, DC, USA, 2020. [Google Scholar]
- Lanese, N. How Far Could the New Coronavirus Spread? Available online: https://www.livescience.com/how-far-will-coronavirus-spread.html (accessed on 2 February 2020).
- Imai, N. Report 3: Transmissibility of 2019-nCoV 2020; Imperial College London: London, UK, 2020. [Google Scholar]
- Shen, M.; Peng, Z.; Xiao, Y.; Zhang, L. Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China. bioRxiv 2020. [Google Scholar] [CrossRef]
- Li, X.; Zai, J.; Wang, X.; Li, Y. Potential of large “first generation” human-to-human transmission of 2019-nCoV. J. Med Virol. 2020, 92, 448–454. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Novel Coronavirus (2019-nCoV) Advice for the Public. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public (accessed on 7 February 2020).
- Riou, J.; Althaus, C.L. Pattern of early human-to-human transmission of Wuhan 2019-nCoV. bioRxiv 2020, 25, 2000058. [Google Scholar]
- Kucharski, A.J.; Russell, T.W.; Diamond, C.; Liu, Y.; Edmunds, J.; Funk, S.; Eggo, R.M. CMMID nCoV working group Early dynamics of transmission and control of COVID-19: A mathematical modelling study. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Ai, L. Modelling the epidemic trend of the 2019-nCOV outbreak in Hubei Province, China. medRxiv 2020. [Google Scholar] [CrossRef]
- Zhao, Q.; Chen, Y.; Small, D.S. Analysis of the epidemic growth of the early 2019-nCoV outbreak using internationally confirmed cases. medRxiv 2020. [Google Scholar] [CrossRef]
- Cao, Z.; Zhang, Q.; Lu, X.; Pfeiffer, D.; Wang, L.; Song, H.; Pei, T.; Jia, Z.; Zeng, D.D. Incorporating Human Movement Data to Improve Epidemiological Estimates for 2019-nCoV. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Bolker, M.B.; Champredon, D.; Earn, D.J.D.; Li, M.; Weitz, S.J.; Grenfell, T.B.; Dushoff, J. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: A new framework and applications to the novel coronavirus (2019-nCoV) outbreak. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Huang, Q.; Herrmann, A. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Chen, T.; Rui, J.; Wang, Q.; Zhao, Z.; Cui, J.-A.; Yin, L. A mathematical model for simulating the transmission of Wuhan novel Coronavirus. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Harvard University. The Handiwork of Good Health; Harvard Health Publishing: Cambridge, MA, USA, 2007. [Google Scholar]
- World Health Organization. Novel Coronavirus (2019-nCoV) Advice for the Public; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- McDonnell, G.; Russell, A.D. Antiseptics and Disinfectants: Activity, Action, and Resistance. Clin. Microbiol. Rev. 1999, 12, 147–179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ellerin, T. The New Coronavirus: What We do and don’t Know; Harvard Health Publishing: Cambridge, MA, USA, 2020. [Google Scholar]
- U.S. Food & Drug Administration. Masks and N95 Respirators; U.S. Food & Drug Administration: Silver Spring, MD, USA, 2020.
- Gajanan, M. Can Face Masks Prevent Coronavirus? Experts Say That Depends; TIME: New York, NY, USA, 2020. [Google Scholar]
- National Health Commission of the People’s Republic of China. Latest Tips to Prevent Novel Coronavirus. Available online: http://en.nhc.gov.cn/2020-02/05/c_76211.htm (accessed on 13 February 2020).
- Government of Canada. 2019 Novel Coronavirus: Prevention and Risks. Available online: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html#re (accessed on 7 February 2020).
- Public Health England. Novel Coronavirus (2019-nCoV) Infection Prevention and Control Guidance. Available online: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/wuhan-novel-coronavirus-wn-cov-infection-prevention-and-control-guidance (accessed on 7 February 2020).
- Australia Government Department of Health. Novel Coronavirus (2019-nCoV). Available online: https://www.health.gov.au/health-topics/novel-coronavirus-2019-ncov (accessed on 7 February 2020).
- Government of Singapore. What You Can do to Protect Yourself from the 2019 Novel Coronavirus. Available online: https://www.gov.sg/article/what-can-you-do-to-protect-yourself-from-2019-ncov (accessed on 7 February 2020).
- Montvida, O.; Dibato, J.E.; Paul, S. Evaluating the Representativeness of US Centricity Electronic Medical Records with Reports from Centers for Disease Control and Prevention: Demographics and Cardiometabolic Conditions. JMIR Med. Inf. 2019. (Preprint). [Google Scholar]
- MedlinePlus. Coronavirus Infections. 2020. Available online: https://medlineplus.gov/coronavirusinfections.html#cat_79 (accessed on 7 February 2020).
- Richman, D.D.; Nathanson, N. Chapter 20—Antiviral Therapy. In Viral Pathogenesis, 3rd ed.; Katze, M.G., Ed.; Academic Press: Boston, BA, USA, 2016; pp. 271–287. [Google Scholar]
- AHFS Patient Medication Information. Oseltamivir. Available online: https://www.ahfsdruginformation.com/ahfs-patient-medication-information/ (accessed on 29 March 2020).
- LV, G. Influenza Virus Neuraminidase Inhibitors; NCBI: Bethesda, MD, USA, 2000. [Google Scholar]
- AHFS Patient Medication Information. Ganciclovir; American Society of Health-System Pharmacists: Bethesda, MD, USA, 2016. [Google Scholar]
- Wishart, D.S.; Feunang, Y.D.; Guo, A.C.; Lo, E.J.; Marcu, A.; Grant, J.R.; Sajed, T.; Johnson, D.; Li, C.; Sayeeda, Z.; et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2017, 46, D1074–D1082. [Google Scholar] [CrossRef] [PubMed]
- Paules, C.I.; Marston, H.D.; Fauci, A.S. Coronavirus Infections—More Than Just the Common Cold. JAMA 2020, 323, 707. [Google Scholar] [CrossRef] [Green Version]
- National Institute of Allergy and Infectious Diseases. Developing Therapeutics and Vaccines for Coronaviruses. Available online: https://www.niaid.nih.gov/diseases-conditions/coronaviruses-therapeutics-vaccines (accessed on 9 February 2020).
- Sheahan, T.P.; Sims, A.C.; Leist, S.R.; Schäfer, A.; Won, J.; Brown, A.J.; Montgomery, S.A.; Hogg, A.; Babusis, D.; Clarke, M.O.; et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun. 2020, 11, 222. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization. WHO R&D Blueprint—Ad-hoc Expert Consultation on Clinical Trials for Ebola Therapeutics. Available online: https://www.who.int/ebola/drc-2018/treatments-approved-for-compassionate-use-update/en/ (accessed on 9 February 2020).
- Ogbru, O. Lopinavir and Ritonavir. Available online: https://www.medicinenet.com/lopinavir_and_ritonavir/article.htm#what_is_lopinavir_and_ritonavir_and_how_does_it_work_mechanism_of_action (accessed on 7 February 2020).
- US Food and Drug Administration. Kaletra; US Food and Drug Administration: Silver Spring, MD, USA, 2000.
- Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhou, X.; Xiao, G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020, 30, 269–271. [Google Scholar] [CrossRef]
- Richardson, P.; Griffin, I.; Tucker, C.; Smith, D.; Oechsle, O.; Phelan, A.; Stebbing, J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 2020, 395, e30–e31. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Zhang, J.; Wang, N.; Li, H.; Shi, Y.; Guo, G.; Liu, K.; Zeng, H.; Zou, Q. Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Liu, X.; Wang, X.-J. Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Tare, D.S.; Kode, S.S.; Hurt, A.C.; Pawar, S.D. Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs. Indian J. Med Res. 2019, 150, 486–491. [Google Scholar]
- Werth, B.J. Cephalosporins; Merck Manual Professional Version: Kenilworth, NJ, USA, 2018. [Google Scholar]
- Shahbaz, K. Cephalosporins: Pharmacology and chemistry. Pharm. Boil. Evaluations 2017, 4, 234. [Google Scholar] [CrossRef]
- Papp-Wallace, K.M.; Endimiani, A.; Taracila, M.A.; Bonomo, R.A. Carbapenems: Past, Present, and Future. Antimicrob. Agents Chemother. 2011, 55, 4943–4960. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Aldred, K.J.; Kerns, R.J.; Osheroff, N. Mechanism of Quinolone Action and Resistance. Biochemistry 2014, 53, 1565–1574. [Google Scholar] [CrossRef] [PubMed]
- Lei, C.; Fu, W.; Qian, K.; Li, T.; Zhang, S.; Ding, M.; Hu, S. Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig 2020. bioRxiv 2020. [Google Scholar] [CrossRef]
- Cohen, J. Scientists are moving at record speed to create new coronavirus vaccines—But they may come too late. Science 2020. [Google Scholar] [CrossRef]
- Pardi, N.; Hogan, M.; Porter, F.W.; Weissman, D. mRNA vaccines—A new era in vaccinology. Nat. Rev. Drug Discov. 2018, 17, 261–279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, A. Inside the Company That’s Hot-Wiring Vaccine Research in the Race to Combat the Coronavirus; TIME: New York, NY, USA, 2020. [Google Scholar]
- Chi, H.; Zheng, X.; Wang, X.; Wang, C.; Wang, H.; Gai, W.; Perlman, S.; Yang, S.; Zhao, J.; Xia, X. DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice. Vaccine 2017, 35, 2069–2075. [Google Scholar] [CrossRef]
- Mazumdar, T. Coronavirus: Scientists Race to Develop a Vaccine; BBC News: London, UK, 2020. [Google Scholar]
- Horie, S.; Gonzalez, H.E.; Laffey, J.G.; Masterson, C. Cell therapy in acute respiratory distress syndrome. J. Thorac. Dis. 2018, 10, 5607–5620. [Google Scholar] [CrossRef]
- Zumla, A.; Hui, D.S.; I Azhar, E.; A Memish, Z.; Maeurer, M. Reducing mortality from 2019-nCoV: Host-directed therapies should be an option. Lancet 2020, 395, e35–e36. [Google Scholar] [CrossRef] [Green Version]
- Ramaiah, A.; Arumugaswami, V. Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Ahmed, S.F.; Quadeer, A.A.; McKay, M.R. Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies. bioRxiv 2020. [Google Scholar] [CrossRef]
- Agence France Presse. Wuhan Virus: Thailand Sees Apparent Success with Flu and HIV Drug Cocktail; The Straits Times: Singapore, 2020. [Google Scholar]
- Berlinger, J. February 3 Coronavirus News; CNN Travel: Atlanta, GA, USA, 2020. [Google Scholar]
- Kurohi, R. Coronavirus: First Patient in Singapore Discharged, Some Given Anti-HIV Drugs; Straits Times: Singapore, 2020. [Google Scholar]
- Channel News Asia. Four-Year-Old Coronavirus Patient in Malaysia Discharged from Hospital; Channel News Asia: Singapore, 2020. [Google Scholar]
- Croft, J.; Parks, B. Both Illinois Coronavirus Patients have been Discharged from the Hospital, in CNN News. Available online: https://edition.cnn.com/2020/02/07/us/illinois-coronavirus-patients-discharge/index.html (accessed on 7 February 2020).
- Ram, S. Available online: https://says.com/my/news/a-40-year-old-wuhanese-man-who-had-become-critical-at-jb-hospital-has-now-recovered (accessed on 14 February 2020).
- Chen, H.; Guo, J.; Wang, C.; Luo, F.; Yu, X.; Zhang, W.; Li, J.; Zhao, D.; Xu, D.; Gong, Q.; et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 2020, 395, 809–815. [Google Scholar] [CrossRef] [Green Version]
- Lu, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends 2020, 14, 69–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, G.; De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov. 2020, 19, 149–150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Nations/Organizations | Epidemic Prevention and Control |
---|---|
Recommendations by various countries | |
China [60] |
|
Canada [61] |
|
United Kingdom [62] |
|
Australia [63] |
|
Singapore [64] |
|
Recommendations by various agencies | |
Chinese Center for Disease Control and Prevention (CDC) [65] |
|
MedlinePlus by the United States National Library of Medicine [66] |
|
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yan, Y.; Shin, W.I.; Pang, Y.X.; Meng, Y.; Lai, J.; You, C.; Zhao, H.; Lester, E.; Wu, T.; Pang, C.H. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. Int. J. Environ. Res. Public Health 2020, 17, 2323. https://doi.org/10.3390/ijerph17072323
Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, Zhao H, Lester E, Wu T, Pang CH. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. International Journal of Environmental Research and Public Health. 2020; 17(7):2323. https://doi.org/10.3390/ijerph17072323
Chicago/Turabian StyleYan, Yuxin, Woo In Shin, Yoong Xin Pang, Yang Meng, Jianchen Lai, Chong You, Haitao Zhao, Edward Lester, Tao Wu, and Cheng Heng Pang. 2020. "The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment" International Journal of Environmental Research and Public Health 17, no. 7: 2323. https://doi.org/10.3390/ijerph17072323